LIFECORE BIOMEDICAL, INC. quarterly report, Q1 FY2009

SEC Filing Summary: Landec Corporation (10-Q)

Business Context and Reporting Period

This is a Quarterly Report on Form 10-Q for Landec Corporation (Note: The input metadata referenced "LIFECORE BIOMEDICAL, INC." but the filing text is explicitly for Landec Corporation). The report covers the fiscal quarter ended March 1, 2009, which was a 14-week quarter occurring once every five years. Landec operates in three segments: Food Products Technology (Apio), Commodity Trading, and Technology Licensing (Intellicoat/Intelimer).

Key Financial Metrics

Metric Three Months Ended
March 1, 2009
Nine Months Ended
March 1, 2009
Total Revenues $53.9 million $183.7 million
Gross Profit $7.6 million $25.3 million
Operating Income $2.5 million $9.3 million
Net Income $1.5 million $5.9 million
Diluted EPS $0.06 $0.22
Cash & Equivalents $47.3 million (as of March 1, 2009)
Marketable Securities
Total Debt None outstanding (Revolving credit line unused)

Material Changes vs. Prior Period

  • Revenue Decline: Total revenues decreased 10% ($5.7 million) for the three months ended March 1, 2009, compared to the same period in 2008. This was driven by a 6% drop in Apio Value-Added unit sales and a 69% drop in Apio Packaging revenues due to timing of contractual payments from Chiquita.
  • Margin Compression: Gross profit decreased 29% for the quarter. The Food Products Technology segment saw gross margins fall from 13.7% to 10.5% due to increased raw material costs for produce.
  • Net Income Drop: Net income fell 61% to $1.5 million for the quarter, primarily due to lower pre-tax income and a higher effective tax rate (42% vs. 27.7% prior year) as the company utilized its net operating loss carryforwards.
  • Working Capital: Accounts receivable decreased by $7.0 million, and accounts payable decreased by $8.9 million, reflecting lower sales volumes and timing of payments.

Outlook, Risks, and Management Commentary

  • Economic Environment: Management notes that the U.S. and international economy is undergoing a period of slowdown and volatility, which may reduce demand for products and lead to more conservative purchasing by customers.
  • SEC Comment Letter: The company received an SEC comment letter on February 27, 2009, regarding its 10-K and prior 10-Qs. While a response was filed, the company cannot predict if the SEC will agree with its disclosures or if financial statement revisions will be required.
  • Customer Concentration: The top five customers accounted for 46% of revenues for the nine months ended March 1, 2009. Costco Wholesale Corp. alone accounted for 20% of revenues.
  • Liquidity: The company generated $6.3 million in operating cash flow for the nine-month period. Management believes existing cash, cash equivalents, and borrowing capacity are sufficient for the next 12 months.
  • Intangible Assets: Management determined that despite economic deterioration, no update to impairment tests for goodwill and intangibles was necessary as of March 1, 2009.

Investor Verification Checklist

  • SEC Resolution: Verify the status of the SEC comment letter response filed on March 27, 2009, and whether any restatements are anticipated.
  • Customer Concentration: Assess the risk associated with Costco representing 20% of total revenue and the top five customers representing 46%.
  • Margin Trends: Monitor the Food Products Technology segment's gross margin, which declined to 10.5% due to raw material costs, to see if this trend persists.
  • Chiquita Agreement: Confirm the impact of the amended Chiquita license agreement on future Apio Packaging revenue recognition.
  • Goodwill Valuation: Review the assumptions used in the Discounted Cash Flow (DCF) analysis for the Food Products Technology reporting unit, given the sensitivity to discount rate changes.